Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN ISIN · CA05368K1003 LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 484 across all filing types
Latest filing 2021-11-12 Regulatory Filings
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Regulatory Filings
2021-11-12 English
Interim financial statements/report – English.pdf
Regulatory Filings
2021-11-12 English
News release - English.pdf
Regulatory Filings
2021-11-12 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of Viola cannabis products in Canada through a partnership with Avicanna. It contains detailed information about the partnership, product offerings, company backgrounds, and forward-looking statements. There are no financial statements, regulatory filings, voting results, or management changes reported. The content is promotional and informative about a business development rather than a formal financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a general corporate announcement about a commercial partnership and product launch. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other specific categories.
2021-11-09 English
News release - English.pdf
Regulatory Filings
2021-11-08 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a press release announcing a management change at Avicanna Inc., specifically the departure of the President and Chief Legal Officer and the ongoing search for a replacement. It includes background information about the company and a forward-looking statements disclaimer. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The content focuses solely on management changes, which aligns with the category for announcements about changes in the company's board or senior management.
2021-11-06 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.